Evonik Venture Capital is the venture capital group of Evonik, one of the worlds leading specialty chemicals companies
Evonik Venture Capital GmbH plans to invest a total of €100 million in highly promising startups with break-through technologies and leading specialist venture capital funds. These investments will focus on Europe, the US and Asia. Investment activities focus on high-growth megatrends; health & nutrition, resource efficiency and advanced materials. Partnering with innovative startups supplements Evonik’s approach of open innovation and creates excellent opportunities for accelerating the development of new businesses and opening up future growth fields. As an active investor and reliable partner, Evonik supports the successful growth of its portfolio companies not only financially, but also with technical expertise and strategic insight.